BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11819035)

  • 1. Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test.
    Redrobe JP; Calo' G; Regoli D; Quirion R
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):164-7. PubMed ID: 11819035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
    Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H
    Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon.
    Rizzi A; Bigoni R; Caló G; Guerrini R; Salvadori S; Regoli D
    Eur J Pharmacol; 1999 Dec; 385(2-3):R3-5. PubMed ID: 10607891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.
    Calo' G; Guerrini R; Bigoni R; Rizzi A; Marzola G; Okawa H; Bianchi C; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2000 Mar; 129(6):1183-93. PubMed ID: 10725267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats.
    Redrobe JP; Calo G; Guerrini R; Regoli D; Quirion R
    Br J Pharmacol; 2000 Dec; 131(7):1379-84. PubMed ID: 11090110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
    Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
    J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
    Bigoni R; Calo' G; Rizzi A; Guerrini R; De Risi C; Hashimoto Y; Hashiba E; Lambert DG; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):565-8. PubMed ID: 10832612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
    Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nphe(1)]nociceptin-(1-13)NH(2) selectively antagonizes nociceptin effects in the rabbit isolated ileum.
    Pheng LH; Calo G; Guerrini R; Regoli D
    Eur J Pharmacol; 2000 Jun; 397(2-3):383-8. PubMed ID: 10844138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness.
    Holanda VA; Medeiros IU; Asth L; Guerrini R; Calo' G; Gavioli EC
    Psychopharmacology (Berl); 2016 Jul; 233(13):2525-32. PubMed ID: 27129865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats.
    Vitale G; Ruggieri V; Filaferro M; Frigeri C; Alboni S; Tascedda F; Brunello N; Guerrini R; Cifani C; Massi M
    Psychopharmacology (Berl); 2009 Dec; 207(2):173-89. PubMed ID: 19711054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
    Tzschentke TM; Rutten K
    Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
    Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
    Redrobe JP; Dumont Y; Fournier A; Quirion R
    Neuropsychopharmacology; 2002 May; 26(5):615-24. PubMed ID: 11927186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptin stimulates locomotion and exploratory behaviour in mice.
    Florin S; Suaudeau C; Meunier JC; Costentin J
    Eur J Pharmacol; 1996 Dec; 317(1):9-13. PubMed ID: 8982713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal nociceptin inhibits septide but not N-methyl-D-aspartate-induced nociceptive behavior in rats.
    Villanueva N; Lastra A; Hidalgo A; Baamonde A; Menéndez L
    Eur J Pharmacol; 2002 Jun; 445(1-2):83-6. PubMed ID: 12065197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.
    Rizzi A; Gavioli EC; Marzola G; Spagnolo B; Zucchini S; Ciccocioppo R; Trapella C; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):968-74. PubMed ID: 17329551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung.
    Corboz MR; Rivelli MA; Egan RW; Tulshian D; Matasi J; Fawzi AB; Benbow L; Smith-Torhan A; Zhang H; Hey JA
    Eur J Pharmacol; 2000 Aug; 402(1-2):171-9. PubMed ID: 10940371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.
    Gavioli EC; Vaughan CW; Marzola G; Guerrini R; Mitchell VA; Zucchini S; De Lima TC; Rae GA; Salvadori S; Regoli D; Calo' G
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):547-53. PubMed ID: 15197534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence.
    Ueda H; Inoue M; Takeshima H; Iwasawa Y
    J Neurosci; 2000 Oct; 20(20):7640-7. PubMed ID: 11027224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.